Frazier Management LLC Adverum Biotechnologies, Inc. Transaction History

Frazier Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.36 - $10.56 $4.83 Million - $15.2 Million	-1,437,028 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$8.53 - $25.64 $1.35 Million - $4.07 Million	158,700 Added 12.41%	1,437,028 $30 Million
Q1 2020 May 13, 2020	BUY	$7.98 - $16.32 $8.06 Million - $16.5 Million	1,009,985 Added 376.38%	1,278,328 $12.5 Million
Q4 2019 Feb 13, 2020	BUY	$5.12 - $12.22 $1.37 Million - $3.28 Million	268,343 New	268,343 $3.09 Million

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $723M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.